tirzepatide and semaglutide therapeutic modality are both injectable medications used in medical weight management—but they act on different metabolic pathways, which is why patient selection matters. Semaglutide (GLP-1 receptor agonist): • Primarily targets appetite Evidence- based, patient centered, and

Semaglutide is available in several formulations approved by the US Food and Drug Administration (FDA): Ozempic: approved for type 2 diabetes but often prescribed off-label for weight loss under medical supervision Wegovy: specifically approved for weight management in adults with obesity or overweight with related health conditions Rybelsus: the oral (pill) version of semaglutide, taken daily rather than by weekly injection Each option has different dosages and indications, and our endocrinologists help you determine which if any best fits your health profile

Other common deficiencies include zinc, folate, selenium, and vitamin B12 13 , micronutrients essential for growth, development, immune function and oxidative balance 14

The objective is to present accurate facts that help to provide clarity to the reader, so that they make informed decisions which are based on science, not on symptoms

Compounding involves creating customized medications to meet the specific needs of individual patients

Novel approaches and targets for treatment of chronic obstructive pulmonary disease

Xue T, Wu X, Chen S, et al